Electrophysiologists at the Austin-based Texas Cardiac Arrhythmia Institute at St. David’s Medical Center are the first in the nation to implant a new defibrillation lead.
The FDA-approved device is a specialized, insulated wire that connects to an implantable cardioverter-defibrillator or cardiac resynchronization therapy device to correct abnormal rhythm, according to a Jan. 30 system news release. The new device is the world’s smallest, catheter-delivered defibrillation lead.
The first procedure was performed by Robert Canby, MD, and Amin Al-Ahmad, MD, on Jan. 7.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
